OptiBiotix Health achieved its highest ever own brand online sales in July

In the update, the company said it had signed agreements with four new partners in Asia for its SlimBiome product since April, who have all placed orders.

The statement added: “Online sales growth has been helped by an improved website, checkout and logistics leading to a 450 per cent increase in the online conversion rate ( the number of sales divided by number of visitors to site), and the opening up of new online channels such as Amazon.

"We now have listings of SlimBiome Medical and Gofigure products on Amazon UK and Amazon Prime, Slimbiome Medical on Amazon Germany, to be followed by Amazon Prime, and Walmart USA.

"We are going through the extensive process of listing products on Amazon India, Amazon UAE, and Amazon US as part of the online internationalisation of our own brand products and investment in marketing to support further sales growth.”

The statement added: “One of our partners has secured an international listing for products containing SlimBiome with Costco, the fifth largest retailer in the world.

"Discussions are ongoing to determine launch plans in a number of territories around the world. Further details will be provided as products are launched in different countries.”

Stephen O’Hara, the chief executive of OptiBiotix Health plc said: “We are making good progress on our aims of getting existing partners returning to forecast, bringing in new partners, particularly in the US and Asia, and expanding e-commerce channels to grow online sales and reduce partner dependency.

"This is all part of plans for each business unit to reach operational profitability, at least on a monthly basis by the end of the calendar year.

He added: “The aim for the second half of the year is to continue our focus on managing costs, growing sales and closing out ongoing discussion with a number of larger partners across first and second generation products to ensure a return on investment from our expansion in our commercial and business development team.”

OptiBiotix Health, which was formed in 2012, brings scientific expertise to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage disease and promote good health.

OptiBiotix has an extensive research and development programme working with academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than 20 international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their microbiome modulators into a range of food and drinks.